Suchergebnisse - "Sessa, C"

PubPharm (422)

1

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer : pathology and molecular biology and early, advanced and recurrent disease

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Ledermann, J. | Matias-Guiu, X. | Amant, F. | +43

2

Reply to the Letter to the Editor 'There is no place for ovarian cancer screening in hereditary breast-ovarian cancer syndromes (in regard to "ESMO Clinical Practice Guideline on risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes")' by W. Tjalma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Sessa, C. | Paluch-Shimon, S. | ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

3

INOVATYON/ ENGOT-ov5 study : Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line

enthalten in: British journal of cancer | 2023

von Colombo, N. | Gadducci, A. | Sehouli, J. | +139

4

Challenges in oncology career : are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey

enthalten in: ESMO open | 2023

von Linardou, H. | Adjei, A. | Bajpai, J. | +18

5

Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes : ESMO Clinical Practice Guideline

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Sessa, C. | Balmaña, J. | Bober, S. | +16

6

Capability of Far-Infrared for the selective identification of red and black pigments in paint layers

enthalten in: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy | 2022

von Giménez, P. | Linares, A. | Sessa, C. | +2

7

The impact of COVID-19 on cancer care and oncology clinical research : an experts' perspective

enthalten in: ESMO open | 2022

von Sessa, C. | Cortes, J. | Conte, P. | +12

CommentIn: ESMO Open. 2022 Aug;7(4):100537. - PMID 35868220

8

Female leadership in oncology-has progress stalled? Data from the ESMO W4O authorship and monitoring studies

enthalten in: ESMO open | 2021

von Berghoff, A. | Sessa, C. | Yang, J. | +18

9

Clinical benefit of systemic therapies for recurrent ovarian cancer-ESMO-MCBS scores

enthalten in: ESMO open | 2021

von Broekman, K. | van Kruchten, M. | van Tinteren, H. | +3

10

Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey

enthalten in: ESMO open | 2021

von Garrido, P. | Adjei, A. | Bajpai, J. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[43]